Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 325 of 499 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/05
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 06/30/08
End: -
Due: -
Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation
Phase: N/A
Priority: Normal
Start: 02/14/23
End: 12/31/33
Due: 12/31/34
Phase: N/A
Priority: Normal
Start: 09/30/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 01/16/18
Due: 01/16/19
Phase: N/A
Priority: Normal
Start: 07/31/00
End: 04/30/02
Due: 04/30/03
Phase: N/A
Priority: Normal
Start: 08/31/94
End: 11/30/09
Due: 11/30/10
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 01/31/09
Due: 01/31/10
Phase: N/A
Priority: Normal
Start: 05/31/10
End: 11/15/14
Due: 11/15/15
Phase: N/A
Priority: Normal
Start: 06/05/28
End: 12/05/28
Due: 12/05/29
Phase: N/A
Priority: Normal
Start: 10/31/08
End: 09/30/10
Due: 09/30/11
Phase: N/A
Priority: Normal
Start: 01/31/04
End: 03/31/10
Due: 03/31/11
Phase: N/A
Priority: Normal
Start: 02/29/12
End: 01/31/18
Due: 01/31/19
Phase: N/A
Priority: Normal
Start: 08/31/05
End: 05/31/08
Due: 05/31/09
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 04/15/23
Due: 04/15/24
Phase: N/A
Priority: Normal
Start: 04/30/02
End: 09/30/06
Due: 09/30/07
Phase: N/A
Priority: Normal
Start: 09/30/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/02
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 08/31/07
End: 01/15/17
Due: 01/15/18
Phase: N/A
Priority: Normal
Start: 03/31/01
End: 05/31/05
Due: 05/31/06
Phase: N/A
Priority: Normal
Start: 12/31/03
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 05/31/12
End: 11/01/19
Due: 11/01/20
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/04
End: 11/30/10
Due: 11/30/11
Phase: N/A
Priority: Normal
Start: 05/31/01
End: 05/31/08
Due: 05/31/09